| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8317295 | Clinical Biochemistry | 2014 | 8 Pages |
Abstract
The performance characteristics suggest that the LDL-P assay is suitable for routine testing in the clinical laboratory on the Vantera Clinical Analyzer, the first automated NMR platform that supports NMR-based clinical assays.
Keywords
FDALDL-PIDLIVDCLIALOQVLDLCLSIHDL-PLDTHDL-CHDLLDL-Cnuclear magnetic resonanceDMSOclinical laboratory standards instituteClinical Laboratory Improvement Amendmentsstandard deviationcardiovascular diseaseIn vitro diagnosticNMRLOD یا Limit of detectionlimit of blankDimethyl sulfoxideCVDFood and Drug AdministrationCoefficient of VariationLobhigh density lipoproteinLow density lipoprotein-cholesterolvery low density lipoproteinIntermediate density lipoproteinlow density lipoproteinLDLHigh density lipoprotein-cholesterollimit of detectionlimit of quantitation
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Steven P. Matyus, Paul J. Braun, Justyna Wolak-Dinsmore, Elias J. Jeyarajah, Irina Shalaurova, Yuan Xu, Suzette M. Warner, Thomas S. Clement, Margery A. Connelly, Timothy J. Fischer,